FTY720, a synthetic sphingosine 1-phosphate (S1P) analogue, inhibits development of atherosclerosis in LDL receptor-deficient mice

被引：0
|
作者：
Nofer, Jerzy Roch
Martine, Bot
Martin, Brodde
van Berkel, Theo J.
Assmann, Gerd
Biessen, Erik A.
机构：
[1] Univ Munster, Munster, Germany
[2] Leiden Univ, Leiden, Netherlands
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [21] Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate
    Chiba, K
    Hoshino, Y
    Ohtsuki, M
    Kataoka, H
    Maeda, Y
    Matsuyuki, H
    Sugahara, K
    Kiuchi, M
    Hirose, R
    Adachi, K
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 102 - 106
  • [22] Antiobesity activity of a sphingosine 1-phosphate analogue FTY720 observed in adipocytes and obese mouse model
    Myung-Hee Moon
    Jae-Kyo Jeong
    Ju-Hee Lee
    Yang-Gyu Park
    You-Jin Lee
    Jae-Won Seol
    Sang-Youel Park
    Experimental & Molecular Medicine, 2012, 44 : 603 - 614
  • [23] Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice
    Klingenberg, Roland
    Nofer, Jerzy-Roch
    Rudling, Mats
    Bea, Florian
    Blessing, Erwin
    Preusch, Michael
    Grone, Hermann J.
    Katus, Hugo A.
    Hansson, Goeran K.
    Dengler, Thomas J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (11) : 2392 - 2399
  • [24] Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
    Mehling, M.
    Johnson, T. A.
    Antel, J.
    Kappos, L.
    Bar-Or, A.
    NEUROLOGY, 2011, 76 (08) : S20 - S27
  • [25] Antiobesity activity of a sphingosine 1-phosphate analogue FTY720 observed in adipocytes and obese mouse model
    Moon, Myung-Hee
    Jeong, Jae-Kyo
    Lee, Ju-Hee
    Park, Yang-Gyu
    Lee, You-Jin
    Seol, Jae-Won
    Park, Sang-Youel
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (10): : 603 - 614
  • [26] Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo
    Hu, Yinghui
    Lee, Xinhua
    Ji, Benxiu
    Guckian, Kevin
    Apicco, Daniel
    Pepinsky, R. Blake
    Miller, Robert H.
    Mi, Sha
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2011, 48 (01) : 72 - 81
  • [27] Sphingosine 1-Phosphate Receptor Modulator FTY720 Suppresses Rat Experimental Autoimmune Prostatitis
    Zhang, Z. -Y.
    Zug, C.
    Schluesener, H. J.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (06) : 546 - 553
  • [28] Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720
    Allende, ML
    Sasaki, T
    Kawai, H
    Olivera, A
    Mi, YD
    van Echten-Deckert, G
    Hajdu, R
    Rosenbach, M
    Keohane, CA
    Mandala, S
    Spiegel, S
    Proia, RL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) : 52487 - 52492
  • [29] SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR TYPE 1 SIGNALING INDUCES AN ANTI-ATHEROGENIC PHENOTYPE IN MACROPHAGES AND ATTENUATES ATHEROSCLEROSIS IN LDL-RECEPTOR-DEFICIENT MICE
    Poti, F.
    Scalera, E.
    Feuerborn, R.
    Fischer, J.
    Arndt, L.
    Varga, G.
    Pardali, E.
    Seidl, M.
    Liebisch, G.
    Rosenbauer, F.
    Renne, T.
    Christoffersen, C.
    Simoni, M.
    Burkhardt, R.
    Nofer, J. -R.
    ATHEROSCLEROSIS, 2020, 315 : E12 - E12
  • [30] The Sphingosine 1-Phosphate Receptor Agonist FTY720 Potently Inhibits Regulatory T Cell Proliferation In Vitro and In Vivo
    Wolf, Anna Maria
    Eller, Kathrin
    Zeiser, Robert
    Duerr, Christoph
    Gerlach, Ulrike V.
    Sixt, Michael
    Markut, Lydia
    Gastl, Guenther
    Rosenkranz, Alexander R.
    Wolf, Dominik
    JOURNAL OF IMMUNOLOGY, 2009, 183 (06): : 3751 - 3760
12345